A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.
Aug 3, 2023
0
1
Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and is currently in human ...
Jul 25, 2023
0
1
Scripps Research scientists have shown that analyzing a certain type of immune cell in the blood can help identify people at risk of developing type 1 diabetes, a life-threatening autoimmune disease. The new approach, if ...
Jul 20, 2023
0
26
Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea.
Jul 19, 2023
0
16
The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.
Jul 3, 2023
0
2
Researchers led by McMaster University professor Gregory Steinberg and postdoctoral research fellow Dongdong Wang have uncovered a key mechanism for promoting weight loss and maintaining the burning of calories during dieting.
Jun 28, 2023
0
226
An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows.
Jun 27, 2023
0
1
What if treating obesity could be as easy as popping an effective pill?
Jun 26, 2023
0
24
After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy—a formulation expressly designed to help users shed pounds—sales of both drugs skyrocketed.
Jun 26, 2023
0
8
The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.
Jun 21, 2023
0
9
